PROM1 and central nervous system cancer: The percentage of CD133+ cells were 98.2% in GSCs-U251 and 98.6% in GSCs-U87, which were similar with those confirmed in glioma-initiating cells isolated from U87 and 4910 glioma xenograft cells (98.4% and 98.8%, respectively) using the same isolated method [25].